Moreover, the 36-month beta value for ZURA is 0.16. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ZURA is 42.24M and currently, short sellers hold a 4.40% of that float. On October 18, 2024, ZURA’s average trading volume was 459.86K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZURA) stock’s latest price update
The stock price of Zura Bio Ltd (NASDAQ: ZURA) has jumped by 7.95 compared to previous close of 4.53. Despite this, the company has seen a gain of 26.68% in its stock price over the last five trading days. businesswire.com reported 2024-09-03 that SACRAMENTO, Calif.–(BUSINESS WIRE)–CPS HR Consulting, a leader in public sector HR consulting, is thrilled to announce a strategic partnership with GovInvest, the pioneer of compensation analytics technology for government agencies. This collaboration aims to combine CPS HR’s renowned compensation consulting expertise with GovInvest’s innovative software platform, offering unparalleled data confidence and decision-making capabilities. Highlights of the Partnership Best-in-Class Consulting + T.
ZURA’s Market Performance
Zura Bio Ltd (ZURA) has seen a 26.68% rise in stock performance for the week, with a 18.40% gain in the past month and a 40.11% surge in the past quarter. The volatility ratio for the week is 8.22%, and the volatility levels for the past 30 days are at 7.20% for ZURA. The simple moving average for the last 20 days is 17.82% for ZURA’s stock, with a simple moving average of 28.33% for the last 200 days.
Analysts’ Opinion of ZURA
Many brokerage firms have already submitted their reports for ZURA stocks, with H.C. Wainwright repeating the rating for ZURA by listing it as a “Neutral.” The predicted price for ZURA in the upcoming period, according to H.C. Wainwright is $5 based on the research report published on September 05, 2024 of the current year 2024.
Piper Sandler, on the other hand, stated in their research note that they expect to see ZURA reach a price target of $26. The rating they have provided for ZURA stocks is “Overweight” according to the report published on May 03rd, 2024.
Ladenburg Thalmann gave a rating of “Buy” to ZURA, setting the target price at $10 in the report published on October 10th of the previous year.
ZURA Trading at 26.08% from the 50-Day Moving Average
After a stumble in the market that brought ZURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.99% of loss for the given period.
Volatility was left at 7.20%, however, over the last 30 days, the volatility rate increased by 8.22%, as shares surge +13.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.53% upper at present.
During the last 5 trading sessions, ZURA rose by +26.68%, which changed the moving average for the period of 200-days by +12.41% in comparison to the 20-day moving average, which settled at $4.15. In addition, Zura Bio Ltd saw 4.71% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZURA starting from Thiara Parvinder, who sale 3,800,000 shares at the price of $2.70 back on Sep 11 ’24. After this action, Thiara Parvinder now owns 1,001,633 shares of Zura Bio Ltd, valued at $10,260,000 using the latest closing price.
Sidhu Someit, the Director of Zura Bio Ltd, sale 51,728 shares at $3.87 during a trade that took place back on Sep 04 ’24, which means that Sidhu Someit is holding 2,085,418 shares at $200,187 based on the most recent closing price.
Stock Fundamentals for ZURA
The total capital return value is set at -0.24. Equity return is now at value -26.74, with -19.90 for asset returns.
Currently, EBITDA for the company is -62.64 million with net debt to EBITDA at 4.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.57.
Conclusion
To wrap up, the performance of Zura Bio Ltd (ZURA) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
